Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression

Autor: Kumar A, Bunker MT, Aaronson ST, Conway CR, Rothschild AJ, Mordenti G, Rush AJ

Publikováno v: Neuropsychiatric Disease and Treatment, Vol Volume 15, Pp 457-468 (2019)

Arun Kumar,1 Mark T Bunker,1 Scott T Aaronson,2 Charles R Conway,3 Anthony J Rothschild,4,5 Giacomo Mordenti,6 Augustus J Rush7,8 1LivaNova USA PLC, Houston, TX, USA; 2Department of Clinical Research, Sheppard Pratt Health System, Baltimore, MD, USA;

Externí odkaz: https://doaj.org/article/5191880c2f714a869125e36c8e9c140e

Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.

Autor: Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA

Publikováno v: Depression & Anxiety (1091-4269); Jul2012, Vol. 29 Issue 7, p587-596, 10p

Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2).

Autor: Sackeim HA; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, USA. Electronic address: has1@columbia.edu., Aaronson ST; Sheppard Pratt Health System and Department of Psychiatry, University of Maryland, Baltimore, MD, USA., Bunker MT; LivaNova PLC, Houston, TX, USA., Conway CR; Department of Psychiatry, Washington University, St. Louis, MO, USA., George MS; Departments of Psychiatry,Neurology,and Neuroscience, Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, SC, USA., McAlister-Williams RH; Northern Centre for Mood Disorders, Translational and Clinical Research Institute, Newcastle University, UK; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK., Prudic J; New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York, NY, USA., Thase ME; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA., Young AH; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, and South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, UK., Rush AJ; Duke-NUS Medical School, Singapore; Duke University, Durham, NC, USA; Texas Tech University, Permian Basin, TX, USA.

Publikováno v: Journal of psychiatric research [J Psychiatr Res] 2024 Aug; Vol. 176, pp. 325-337. Date of Electronic Publication: 2024 Jun 12.

Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.

Autor: Aaronson ST; Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland.; Department of Psychiatry, University of Maryland, Baltimore., van der Vaart A; Department of Psychiatry, University of Maryland, Baltimore., Miller T; Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland., LaPratt J; Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland., Swartz K; Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland., Shoultz A; Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland., Lauterbach M; Institute for Advanced Diagnostics and Treatment, Sheppard Pratt Health System, Baltimore, Maryland.; Department of Psychiatry, University of Maryland, Baltimore., Sackeim HA; Department of Psychiatry, Columbia University, New York.; Department of Radiology, Columbia University, New York., Suppes T; VA Palo Alto Health Care System, Palo Alto, California.; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California.

Publikováno v: JAMA psychiatry [JAMA Psychiatry] 2024 Jun 01; Vol. 81 (6), pp. 555-562.

A Pilot Study of High-Frequency Transcranial Magnetic Stimulation for Bipolar Depression.

Autor: Aaronson ST; Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt Health System, Baltimore, Maryland.; Corresponding Author: Scott T. Aaronson, MD, Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt Health System, 6501 N Charles St, Baltimore, MD 21204 (SAaronson@sheppardpratt.org)., Goldwaser EL; Department of Psychiatry, Interventional Psychiatry Program, Weill Cornell Medicine, New York, New York., Croarkin PE; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Geske JR; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., LeMahieu A; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota., Sklar JH; Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt Health System, Baltimore, Maryland., Kung S; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.

Publikováno v: The Journal of clinical psychiatry [J Clin Psychiatry] 2024 May 20; Vol. 85 (2). Date of Electronic Publication: 2024 May 20.